Morgan R.L. Lichtenstein, MD, on Insurance Plan, Prior Authorization, and Time to Receipt of Oral Anticancer Drugs
Morgan R.L. Lichtenstein, MD, of Columbia University Medical Center, discusses a single-center prospective study examining the complex relationship between time to oral oncolytic receipt and clinical or process-related factors, such as prior authorization, diagnosis, and insurance type.